Silvercrest Asset Management Group LLC Bridge Bio Pharma, Inc. Transaction History

Silvercrest Asset Management Group LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.21 - $12.14 $1.34 Million - $3.12 Million	-256,756 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$7.34 - $17.16 $22,240 - $51,994	3,030 Added 1.19%	256,756 $2.61 Million
Q4 2021 Feb 14, 2022	BUY	$11.38 - $53.41 $2.05 Million - $9.61 Million	179,992 Added 244.11%	253,726 $4.23 Million
Q3 2021 Nov 15, 2021	BUY	$46.87 - $64.24 $1.29 Million - $1.76 Million	27,425 Added 59.22%	73,734 $3.46 Million
Q2 2021 Aug 16, 2021	BUY	$46.47 - $63.93 $49,304 - $67,829	1,061 Added 2.34%	46,309 $2.82 Million
Q1 2021 May 17, 2021	SELL	$55.47 - $72.35 $1.96 Million - $2.56 Million	-35,422 Reduced 43.91%	45,248 $2.79 Million
Q4 2020 Feb 16, 2021	SELL	$38.38 - $71.11 $494,027 - $915,327	-12,872 Reduced 13.76%	80,670 $5.74 Million
Q3 2020 Nov 16, 2020	BUY	$27.2 - $42.19 $2.54 Million - $3.95 Million	93,542 New	93,542 $3.51 Million

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.42B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.